• The technology described in this briefing is the ReStore Soft Exo‑Suit. It is a powered exosuit worn by adults who are having gait rehabilitation to relearn to walk after a stroke or brain injury.

  • The innovative aspects are that the real-time data from sensors in the shoes and on the affected leg are used to adjust the mechanical assistance to match the user's natural gait and to enhance propulsion symmetry.

  • The intended place in therapy would be in rehabilitation clinics, in addition to standard care, for people who are having physiotherapy after a stroke or brain injury that has affected the movement in one of their legs.

  • The main points from the evidence summarised in this briefing are from 3 non-comparative feasibility and safety studies, including a total of 53 adults recovering from stroke, in physiotherapy clinics in the US. They show that while wearing ReStore some gait metrics were improved.

  • Key uncertainties around the evidence are that it is at an early stage in evidence generation and there is currently no comparative evidence or studies showing the long-term impact on gait rehabilitation outcomes. Two of the studies used early versions of ReStore, and so may not reflect outcomes from the current version.

  • The cost of ReStore is £22,995 per unit (excluding VAT) with around £4,000 per year in consumables (when used by 10 patients per month and both cartridges are replaced yearly). As an add-on intervention, the resource impact would be greater than standard care.